GO:0006825 copper ion transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006825 copper ion transport describes the directed movement of copper (Cu) ions into, out of, or within a cell, or between cells, via transporters or pores.
• Copper is an essential trace element but becomes toxic when overloaded, so transport must be tightly regulated; deficiency and overload both cause disease.
• Key transport proteins include ATP7A, ATP7B, SLC31A1 (CTR1), ATOX1, CCS, and SCO1, which mediate uptake, intracellular delivery, and efflux.
• In plants, copper ion transport is required for ethylene signaling, with ATX1 and RAN1 functioning in the pathway.
• Dysregulated copper transport is linked to Wilson disease, breast cancer, colon cancer, and impaired kinesin-dependent transport.
• Experimental models for studying copper ion transport include CRISPR knockout, point-mutation knock-in, and overexpression cell lines, combined with transport assays and imaging.
Description
Copper ion transport (GO:0006825) is the biological process that mediates the directed movement of copper (Cu) ions into, out of, or within a cell, or between cells, by means of transporters or pores. Copper is an essential cofactor for enzymes involved in respiration, antioxidant defense, and neurotransmitter synthesis, but free copper can catalyze harmful reactions, so its distribution must be precisely controlled. This process is fundamental to understanding how cells maintain copper homeostasis and how its disruption contributes to disease. Researchers study copper ion transport to dissect mechanisms of metal homeostasis, to identify therapeutic targets in cancer and metabolic disorders, and to engineer cell models that mimic human copper-related pathologies. The transport machinery includes membrane transporters, intracellular chaperones, and regulatory proteins that together ensure copper reaches the right destination without causing toxicity. In this article, we integrate the QuickGO definition with published literature to provide a research-grade overview of copper ion transport, its genes, regulation, disease relevance, and methods for experimental investigation.
copper ion transport At A Glance
| GO ID | GO:0006825 |
|---|---|
| GO term | copper ion transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of copper ions across membranes or within cells via transporters or pores |
| Key transporters | ATP7A, ATP7B, SLC31A1 (CTR1), ATOX1, CCS, SCO1 |
| Associated diseases | Wilson disease, breast cancer, colon cancer, copper overload toxicity |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, transport assays, imaging |
What Is GO:0006825?
According to the Gene Ontology, copper ion transport (GO:0006825) is the directed movement of copper (Cu) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses all mechanisms that move copper ions across membranes or within cellular compartments, ensuring copper availability for cuproproteins while preventing toxic accumulation.
Why Is copper ion transport Important in Cell Biology?
Copper ion transport is critical because copper is both essential and potentially toxic; its misregulation leads to severe metabolic and neurological disorders, and it influences cancer progression and immune responses. Understanding this process provides insights into fundamental cell biology and offers targets for therapeutic intervention in diseases such as Wilson disease and various cancers.
• Copper is a required cofactor for cytochrome c oxidase, superoxide dismutase, and other enzymes, making transport essential for cellular respiration and antioxidant defense.
• Deficiency or overload of copper causes disease, including Wilson disease and Menkes disease, highlighting the need for tight transport regulation.
• Copper transport proteins are implicated in cancer; expression changes in breast cancer correlate with tumor progression.
• In colon cancer, efficient copper ion transport can trigger cuproptosis and enhance immunotherapy responses.
• Plant copper transport is required for ethylene signaling, linking metal homeostasis to hormone pathways.
• Elevated copper ion levels can impair kinesin-dependent transport processes, affecting intracellular trafficking.
• Copper speciation influences its transport pathway in intestinal cells, affecting bioavailability.
• Copper ions can modulate ion transport across membranes, as shown by Cl(-)/OH(-) exchange in erythrocytes.
What Happens During copper ion transport?
Copper uptake at the plasma membrane
In simple terms: Copper enters the cell through specialized transporter proteins on the cell surface.
The first step in copper ion transport is the uptake of copper across the plasma membrane. In mammalian cells, the high-affinity copper transporter SLC31A1 (CTR1) mediates the majority of copper uptake. This process is energy-dependent and tightly regulated to prevent excess copper from entering the cell. In intestinal cells, copper speciation affects its transport pathway, with different copper complexes being absorbed via distinct mechanisms. In plants, copper uptake is also mediated by specific transporters, and the small molecule triplin has been used to reveal copper ion transport in ethylene signaling from ATX1 to RAN1.
Intracellular copper delivery to cuproproteins
In simple terms: Once inside, copper is handed off to chaperone proteins that deliver it to target enzymes.
After uptake, copper is bound by intracellular chaperones such as ATOX1 and CCS, which deliver it to specific cuproproteins. ATOX1 transports copper to the ATP7A and ATP7B transporters in the trans-Golgi network, while CCS delivers copper to superoxide dismutase 1 (SOD1). This chaperone-mediated delivery ensures that copper is not free to participate in harmful reactions. The process is essential for the maturation of copper-dependent enzymes involved in respiration and antioxidant defense.
Copper efflux and sequestration
In simple terms: Excess copper is pumped out of the cell or stored safely to avoid toxicity.
When intracellular copper levels rise, efflux pumps such as ATP7A and ATP7B move copper out of the cell or into secretory vesicles. ATP7B is critical for biliary copper excretion, and its dysfunction causes Wilson disease. ATP7A is important for copper export from cells and its deficiency leads to Menkes disease. In addition, copper can be sequestered by metallothioneins. The balance between uptake, delivery, and efflux determines overall copper homeostasis.
Copper transport in signaling and disease
In simple terms: Copper movement is connected to cell signaling and can go wrong in diseases like cancer.
Copper ion transport is not only a housekeeping process; it also participates in signaling pathways. In plants, copper transport from ATX1 to RAN1 is required for ethylene signaling. In cancer, altered expression of copper transport system members is observed in breast cancer, and efficient copper ion transport can trigger cuproptosis and enhance immunotherapy in colon cancer. Elevated copper ion levels can also impair kinesin-dependent transport processes, linking copper to intracellular trafficking. These findings underscore the broad importance of copper ion transport in physiology and disease.
Key Genes Involved in GO:0006825 copper ion transport
The following genes encode proteins that directly mediate or regulate copper ion transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP7A | Copper-transporting ATPase; mediates copper efflux from cells | Mutations cause Menkes disease; studied for copper export mechanisms |
| ATP7B | Copper-transporting ATPase; facilitates biliary copper excretion | Mutations cause Wilson disease; variants show diverse functional properties |
| SLC31A1 (CTR1) | High-affinity copper uptake transporter at plasma membrane | Key regulator of cellular copper influx; target in cancer research |
| ATOX1 | Copper chaperone; delivers copper to ATP7A/ATP7B | Essential for intracellular copper trafficking; studied in ethylene signaling in plants |
| CCS | Copper chaperone for SOD1; delivers copper to SOD1 | Important for antioxidant defense; linked to copper homeostasis |
| SCO1 | Copper chaperone; involved in cytochrome c oxidase assembly | Required for mitochondrial respiration; copper transport to mitochondria |
| COX17 | Copper chaperone; delivers copper to mitochondria | Facilitates copper transport for cytochrome c oxidase |
| MT1A | Metallothionein; binds and sequesters copper | Protects against copper toxicity; regulates free copper levels |
| RAN1 | Copper-transporting ATPase in plants; involved in ethylene signaling | Studied using triplin to reveal copper transport from ATX1 to RAN1 |
| ATX1 | Copper chaperone in plants; delivers copper to RAN1 | Revealed by triplin in ethylene signaling pathway |
| SLC31A2 | Copper transporter; may mediate uptake | Potential modifier of copper homeostasis |
| ATP7A variants | Altered copper transport activity | Studied for functional consequences in disease |
| ATP7B variants | Diverse functional properties in copper transport | Associated with Wilson disease phenotypes |
| SOD1 | Copper-zinc superoxide dismutase; requires copper for activity | Maturation depends on CCS-mediated copper delivery |
| Cytochrome c oxidase | Mitochondrial enzyme complex; requires copper for activity | Assembly depends on SCO1 and COX17 |
| Kinesin motor proteins | Intracellular transport; affected by elevated copper | Impaired by high copper ion levels |
| Cl(-)/OH(-) exchanger | Anion exchange; modulated by cuprous ions | Studied in lamprey erythrocyte membrane |
How Is copper ion transport Regulated?
Copper ion transport is regulated at multiple levels to maintain homeostasis. Intracellular copper levels control the trafficking of ATP7A and ATP7B between the trans-Golgi network and the plasma membrane; high copper induces relocalization of ATP7B to vesicles for excretion. The expression of copper transporters such as SLC31A1 can be regulated by copper availability, and chaperones like ATOX1 and CCS respond to copper status. In plants, copper transport in ethylene signaling is modulated by the small molecule triplin, which affects the ATX1-RAN1 pathway. Additionally, copper speciation influences its transport pathway in intestinal cells, indicating that chemical form affects regulation. Overall, a network of transporters, chaperones, and regulatory proteins ensures copper is delivered safely and excess is removed.
copper ion transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP7B | Wilson disease; copper accumulation in liver and brain | Knockout or point-mutation knock-in of ATP7B in hepatocyte cell lines |
| ATP7A | Menkes disease; copper deficiency | Knockout of ATP7A in fibroblast or neuronal cells |
| SLC31A1 | Breast cancer; altered copper uptake | Overexpression or knockout in breast cancer cell lines |
| Copper transport genes | Colon cancer; cuproptosis and immunotherapy | Knockout of transport genes in colon cancer cells followed by cuproptosis induction |
| Kinesin motor proteins | Impaired transport by elevated copper | Point mutation in kinesin genes to mimic copper effects |
Wilson disease and copper transport dysfunction
Wilson disease is an autosomal recessive disorder caused by mutations in ATP7B, a copper-transporting ATPase essential for biliary copper excretion. Diverse functional properties of Wilson disease ATP7B variants have been characterized, revealing that many mutations impair copper transport activity, leading to copper accumulation in the liver and brain. This highlights the critical role of copper ion transport in human health and provides a paradigm for studying transport defects.
Copper transport in cancer
Altered copper ion transport is increasingly recognized in cancer. In breast cancer, roles of copper transport system members have been investigated, showing that expression changes correlate with tumor biology. In colon cancer, efficient copper ion transport can trigger in situ photothermia and cuproptosis, boosting immunotherapy responses. These findings suggest that targeting copper transport pathways may offer therapeutic opportunities.
Copper overload and cellular toxicity
Elevated copper ion levels can cause cellular damage. For example, high copper concentrations impair kinesin-dependent transport processes, affecting intracellular trafficking. Copper ions can also modulate ion transport across membranes, as shown by cuprous ion-induced Cl(-)/OH(-) exchange in lamprey erythrocytes. These effects underscore the need for tight regulation of copper ion transport to prevent toxicity.
From copper ion transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP7B impair copper efflux? | ATP7B knockout cell line (e.g., HepG2) |
| How do Wilson disease variants affect copper transport? | Point-mutation knock-in of ATP7B variants |
| Can overexpression of SLC31A1 increase copper uptake? | SLC31A1 overexpression in breast cancer cells |
| Does copper transport trigger cuproptosis in colon cancer? | Knockout of copper transport genes in colon cancer cells |
| How does copper affect kinesin-dependent transport? | Point mutation in kinesin genes or copper-treated cells |
| What is the role of ATOX1 in ethylene signaling? | Knockout of ATX1 in plant models |
How to Study the copper ion transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 64Cu uptake/efflux assay | Rate of copper transport across membranes | Assessing SLC31A1 or ATP7B function |
| Fluorescent copper imaging | Intracellular copper distribution and trafficking | Visualizing ATP7B relocalization |
| CRISPR knockout | Loss-of-function effects on copper transport | Studying ATP7B or SLC31A1 in cell lines |
| Point mutation knock-in | Effect of specific variants on transport activity | Modeling Wilson disease ATP7B variants |
| Overexpression | Gain-of-function effects on copper uptake/efflux | SLC31A1 overexpression in breast cancer cells |
| Caco-2 transport assay | Copper speciation and transport pathway | Intestinal copper absorption studies |
| Kinesin motility assay | Impact of copper on motor protein function | Assessing copper toxicity |
| Plant ethylene signaling assay | Copper transport in hormone signaling | ATX1-RAN1 pathway studies |
Transport assays
Copper transport activity can be measured using radioactive copper (64Cu) uptake or efflux assays in cell lines. These assays quantify the rate of copper movement across membranes and are used to assess the function of transporters such as SLC31A1 and ATP7B. In intestinal cells, copper speciation and transport pathway can be studied using Caco-2 cell monolayers.
Imaging and localization
Fluorescent copper sensors and tagged transporters enable visualization of copper distribution and trafficking in live cells. For example, GFP-tagged ATP7B can be used to monitor copper-induced relocalization. In plants, triplin has been used to reveal copper ion transport in ethylene signaling.
Genetic and biochemical approaches
CRISPR knockout, point mutation, and overexpression models allow dissection of gene function in copper transport. Biochemical assays such as immunoblotting and activity assays for cuproproteins (e.g., SOD1, cytochrome c oxidase) assess the impact of transport defects. Variant functional studies for ATP7B provide insights into disease mechanisms.
Omics and bioinformatics
Transcriptomics and proteomics can reveal global changes in copper transport gene expression under different conditions. Bioinformatics analysis of copper transport system members in cancer datasets has identified correlations with clinical outcomes. Such approaches help prioritize targets for further study.
How CRISPR Can Be Used to Study GO:0006825 copper ion transport
Knockout
CRISPR knockout of copper transport genes such as ATP7B or SLC31A1 allows researchers to study loss-of-function phenotypes, including impaired copper efflux or uptake. For example, ATP7B knockout cells accumulate copper and model Wilson disease. Knockout of SLC31A1 reduces copper uptake and can affect cell proliferation.
Point Mutation
Point mutation knock-in using CRISPR can replicate disease-associated variants, such as those in ATP7B found in Wilson disease patients. These models help determine how specific amino acid changes affect copper transport activity and protein trafficking.
Knock-in
Knock-in of tagged versions of copper transporters (e.g., GFP-ATP7B) enables real-time imaging of protein localization and trafficking in response to copper levels. This approach is valuable for understanding dynamic regulation of copper transport.
Overexpression
CRISPR activation or cDNA overexpression can increase levels of copper transport proteins like SLC31A1, leading to enhanced copper uptake. Overexpression models are useful for studying gain-of-function effects and for screening compounds that modulate copper transport.
How EDITGENE Supports copper ion transport Research
Researchers studying copper ion transport-related genes often need to determine whether a candidate gene is causally involved in copper homeostasis, disease progression, or therapeutic response. Generating precise genetic models is essential to validate findings from correlative studies and to dissect molecular mechanisms.
Contact EDITGENE today to design your custom CRISPR model for copper ion transport research.
Frequently Asked Questions About copper ion transport
What is copper ion transport?
Copper ion transport (GO:0006825) is the directed movement of copper ions into, out of, or within a cell, or between cells, by means of transporters or pores.
What genes are involved in copper ion transport?
Key genes include ATP7A, ATP7B, SLC31A1 (CTR1), ATOX1, CCS, SCO1, and COX17, among others.
How is copper ion transport regulated?
It is regulated by copper levels, which control transporter trafficking and expression, as well as by chaperones and speciation.
What diseases are associated with copper ion transport?
Wilson disease, Menkes disease, breast cancer, and colon cancer are linked to copper transport dysfunction.
What is the role of ATP7B in copper transport?
ATP7B is a copper-transporting ATPase that facilitates biliary copper excretion; mutations cause Wilson disease.
How can I study copper ion transport in the lab?
Common methods include 64Cu transport assays, fluorescent imaging, CRISPR knockout, and overexpression models.
What is cuproptosis and how does it relate to copper transport?
Cuproptosis is a copper-dependent cell death mechanism; efficient copper ion transport can trigger it in colon cancer cells.
Does copper affect kinesin-dependent transport?
Yes, elevated copper ion levels can impair kinesin-dependent transport processes.
What is the role of copper in plant ethylene signaling?
Copper transport from ATX1 to RAN1 is required for ethylene signaling, as revealed by triplin.
How does copper speciation affect its transport?
Copper speciation influences the transport pathway in intestinal Caco-2 cells, affecting bioavailability.
Conclusion
Copper ion transport (GO:0006825) is a fundamental biological process that ensures copper is delivered to cuproproteins while preventing toxicity. Dysregulation of this process is implicated in Wilson disease, Menkes disease, and various cancers, making it a rich area for research. By leveraging CRISPR models and advanced methods, researchers can dissect the molecular mechanisms of copper transport and develop targeted therapies.
References
- 1. Scheiber I et al.. 2013. Copper: effects of deficiency and overload.. Met Ions Life Sci 13:359-87 PMID: 24470097
- 2. Zhang Y et al.. 2026. Efficient copper ion transport triggers in situ photothermia and cuproptosis for boosting colon cancer immunotherapy.. Biomaterials 327:123759 PMID: 41045759
- 3. Huster D et al.. 2012. Diverse functional properties of Wilson disease ATP7B variants.. Gastroenterology 142(4):947-956.e5 PMID: 22240481
- 4. Li W et al.. 2017. Triplin, a small molecule, reveals copper ion transport in ethylene signaling from ATX1 to RAN1.. PLoS Genet 13(4):e1006703 PMID: 28388654
- 5. Chen Y et al.. 2024. Roles of Copper Transport Systems Members in Breast Cancer.. Cancer Med 13(24):e70498 PMID: 39676279
- 6. Bogdanova AY et al.. 1999. Copper effects on ion transport across lamprey erythrocyte membrane: Cl(-)/OH(-) exchange induced by cuprous ions.. Toxicol Appl Pharmacol 159(3):204-13 PMID: 10486307
- 7. Wu M et al.. 2023. Correlation between copper speciation and transport pathway in Caco-2 cells.. J Sci Food Agric 103(4):1895-1900 PMID: 36287610
- 8. Böhm KJ. 2015. Elevated copper ion levels as potential cause of impaired kinesin-dependent transport processes.. Arch Toxicol 89(4):565-72 PMID: 24853401
